Kuopio, Finland

Pauliina Lehtolainen

This inventor holds 1 USPTO granted patent. Top assignee: Ark Therapeutics Limited. Active years: 2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Pauliina Lehtolainen. Retrieved from https://idiyas.com/inventor/pauliina-lehtolainen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2007

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Pauliina Lehtolainen: Innovator in Biotin-Binding Receptors

Introduction

Pauliina Lehtolainen is a notable inventor based in Kuopio, Finland. She has made significant contributions to the field of biotechnology, particularly in the development of novel proteins that interact with biotinylated molecules. Her work has implications for various applications in medical and research settings.

Latest Patents

Lehtolainen holds a patent titled "Nucleic acids encoding biotin-binding receptors." This invention pertains to a novel transmembrane protein capable of binding to biotinylated molecules. The protein comprises a cytoplasmic domain, a membrane-spanning domain, and an extracellular domain, wherein the extracellular domain exhibits biotin-binding activity. She has 1 patent to her name.

Career Highlights

Pauliina Lehtolainen is associated with Ark Therapeutics Limited, where she continues to advance her research and innovations. Her work is characterized by a commitment to enhancing the understanding of biotin-binding proteins and their potential applications.

Collaborations

Lehtolainen has collaborated with notable colleagues, including Varpu Marjomaki and Seppo Yla-Herttuala. These collaborations have contributed to the advancement of her research and the development of innovative solutions in biotechnology.

Conclusion

Pauliina Lehtolainen is a pioneering inventor whose work in biotin-binding receptors showcases her expertise and dedication to advancing biotechnology. Her contributions are valuable to the scientific community and hold promise for future innovations.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…